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Abstract
Syncollin is a 16-kDa protein found predominantly in the zymogen granules of pan-
creatic acinar cells, with expression at lower levels in intestinal epithelial cells and
neutrophils. Here, we used Strep-tagged syncollin isolated from the supernatant of
transiently transfected mammalian cells to test the hypothesis that syncollin has
antibacterial properties, which might enable it to play a role in host defence in the
gut and possibly elsewhere. We show that syncollin is an exceptionally thermostable
protein with a circular dichroism spectrum consistent with a predominantly beta-
sheet structure. Syncollin binds to bacterial peptidoglycan and restricts the growth of
representative Gram-positive (Lactococcus lactis) and Gram-negative (Escherichia coli)
bacteria. Syncollin induces propidium iodide uptake into E. coli (but not L. lactis), indi-
cating permeabilisation of the bacterial membrane. It also causes surface structural
damage in both L. lactis and E. coli, as visualised by scanning electron microscopy. We
propose that syncollin is a previously unidentified member of a large group of antimi-
crobial polypeptides that control the gut microbiome.
Take Aways
• Syncollin is a 16-kDa protein found in pancreatic zymogen granules.
• Syncollin is highly thermostable and has a predominantly beta-sheet structure.
• Syncollin binds peptidoglycan and restricts the growth of L. lactis and E. coli.
• Syncollin causes propidium iodide uptake into E. coli (but not L. lactis).
• Syncollin causes surface structural damage in both L. lactis and E. coli.
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1 | INTRODUCTION
Syncollin is a 16-kDa protein that was originally isolated from the pan-
creatic zymogen granule (ZG; Edwardson, An, & Jahn, 1997). The pro-
tein is present free within the ZG lumen and also tightly associated
with the luminal leaflet of the ZG membrane (An, Hansen, Hodel,
Jahn, & Edwardson, 2000). Syncollin is able to oligomerise, and atomic
force microscopy images of the protein bound to lipid bilayers reveal
doughnut-shaped structures (Geisse, Wäsle, Saslowsky, Henderson, &
Abbreviations: BSA, bovine serum albumin; CD, circular dichroism; CHAPS,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; DMEM, Dulbecco's modified
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Edwardson, 2002). Consistent with this ‘pore-like’ appearance,
syncollin is able to permeabilise both the erythrocytes (Wäsle, Hays,
Rhodes, & Edwardson, 2004) and liposomes (Geisse et al., 2002).
Syncollin is expressed not only in the exocrine pancreas but also
in the gut and the spleen (Edwardson et al., 1997; Tan & Hooi, 2000).
In the rat gut, it is present principally in epithelial cells lining the proxi-
mal duodenum and the colon. Expression of syncollin in the gut is
almost undetectable until rats begin suckling, when expression rises
rapidly; further, syncollin expression falls upon starvation and then
rebounds upon refeeding (Tan & Hooi, 2000). Syncollin is also found
in azurophilic granules of human neutrophils and is secreted from
these cells upon stimulation (Bach et al., 2006). These observations
suggest that syncollin might play a role in host defence, as first pro-
posed by Bach et al. (2006).
There is evidence for the involvement of syncollin in a number of
disease states, particularly related to the gut. For instance, syncollin
expression was found to be strongly down-regulated in the colon
when a bacterial suspension was administered to germ-free mice
(Fukushima, Funayama, Ogawa, Takahashi, & Sasaki, 2003) and in
mice with chemically induced colitis-associated cancer (Li et al., 2014).
In addition, syncollin mRNA is significantly reduced in intestinal epi-
thelia taken from patients with ulcerative colitis (but not Crohn's dis-
ease; Fukushima et al., 2003). Finally, syncollin levels are significantly
elevated in both pancreatic juice (Makawita et al., 2011) and serum
taken from pancreatic cancer patients (Makawita et al., 2013),
suggesting that it might be a useful pancreatic cancer biomarker.
Since syncollin is a component of the pancreatic juice and is impli-
cated in a number of gut disease states, it is tempting to speculate
that it may be active in the gut. We set out to test this hypothesis.
Here, we show that syncollin is a very stable protein, consistent with
a function in the pancreatic juice. It binds to bacterial peptidoglycan
and restricts the growth of representative Gram-positive and Gram-
negative bacteria, reducing the viability of the latter. We also show
that syncollin causes profound structural changes to the surface of
bacteria. We propose that syncollin might be a previously unidentified
member of a large group of antimicrobial polypeptides that control
the gut microbiome. Further, the fact that syncollin is known to be
secreted in response to activation of human neutrophils suggests that
it might be involved in host defence more widely.
2 | RESULTS
2.1 | Purification of syncollin-Strep
tsA-201 cells were transfected with a syncollin-Strep construct in
pcDNA3.1, and syncollin-Strep was purified from cell supernatants
using the Strep-Tactin XT™ system. Following biotin elution of
syncollin from Strep-Tactin XT™ beads, the protein ran at 20 kDa
and appeared as a triple band on silver-stained gels and immunoblots
(Figure 1a). Analysis of these bands by mass spectroscopy indicated
that all three are syncollin. We could not find any evidence for post-
translational modification of the protein. We therefore propose that
the three bands represent differentially folded (and possibly differen-
tially disulfide bonded) forms.
2.2 | Syncollin quality control
As a quality control measure, the purified syncollin-Strep was checked
for two properties known to be hallmarks of native syncollin – the
F IGURE 1 Isolation and characterization of syncollin-Strep.
(a) Analysis of isolated syncollin-Strep by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie
blue staining (left) or immunoblotting (right). Molecular mass markers
(in kDa) are indicated. (b) Immunoblot of syncollin-Strep after SDS-
PAGE in the absence and presence of β-mercaptoethanol (10% [v/v]).
(c) Interaction of syncollin-Strep with syntaxin 2. Syncollin-Strep was
incubated with either glutathione S-transferase (GST)-syntaxin 2, or
GST alone, bound to glutathione-Sepharose™, and loaded, bound and
unbound samples were analysed by immunoblotting. Syncollin-Strep
eluted from GST-syntaxin 2 with free reduced glutathione (15 mM) was
also analysed. Since the polyclonal anti-syncollin antibody used also
recognises GST, only the region of the blot where syncollin migrates is
shown, for clarity. (d) Circular dichroism (CD) spectra of syncollin-Strep
at various temperatures. The results presented in (a) are representative
of those from 60 syncollin-Strep purifications; results in (b–d) are
representative of those from two experiments
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presence of disulfide bonds (An et al., 2000) and the ability to bind to
syntaxin 2 (Edwardson et al., 1997). Syncollin was analysed by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) in
either the presence or absence of β-mercaptoethanol followed by
immunoblotting. The immunoblot (Figure 1b) shows that the protein
migrated more slowly in the presence than in the absence of
β-mercaptoethanol, consistent with unfolding upon reduction of its
disulfide bonds. As shown in Figure 1c, syncollin-Strep bound to glu-
tathione S-transferase (GST)-syntaxin 2 (but not to GST alone)
attached to GSH-Sepharose™ beads and could be eluted upon addi-
tion of reduced glutathione. Hence, at least two key characteristics of
the native protein are retained in purified recombinant syncollin-
Strep.
Following secretion into the pancreatic juice, syncollin will enter
an environment rich in proteolytic activity. One might expect, there-
fore, that its structure would be highly stable. To test this hypothesis,
the thermal stability of the protein was assessed using circular dichro-
ism (CD) spectroscopy. The CD spectrum of syncollin-Strep (10 μM in
10 mM sodium phosphate, pH 8.0 containing 0.1% [w/v] CHAPS),
had two peaks: a negative peak at approximately 218 nm and a posi-
tive peak at approximately 234 nm (Figure 1d), consistent with a pre-
dominantly beta-sheet structure. When the protein was subjected to
a temperature ramp up to 90C, both peaks were reduced in ampli-
tude, although complete unfolding did not occur, indicating that the
protein does indeed have a very high thermal stability.
2.3 | Syncollin binds to bacterial peptidoglycan
To explore a potential role for syncollin in host defence, we first
examined whether syncollin-Strep binds to bacterial peptidoglycan.
Syncollin-Strep or BSA was incubated with peptidoglycan (320 μg),
and the peptidoglycan was pelleted by centrifugation. The majority of
the syncollin-Strep was found in the pellet, whereas all of the BSA
remained in the supernatant (Figure 2). In the absence of peptidogly-
can, syncollin-Strep remained in the supernatant. These results sug-
gest that syncollin is likely to bind to bacterial cell walls.
2.4 | Syncollin restricts bacterial growth
To assess whether there is a functional effect of syncollin binding to
bacteria, we determined the effect of various concentrations of
syncollin-Strep on the growth of Gram-positive Lactococcus lactis and
Gram-negative Escherichia coli. Increasing concentrations of syncollin-
Strep caused a shift to the right of the L. lactis growth curve (optical
density (OD) 600 nm versus time), reaching a >200-min time delay to
reach the exponential phase at 163 μg/ml (8 μM) syncollin-Strep
(Figure 3a). The T50 value (the time taken for the curve to reach half
of its maximal OD) became significantly different from control at this
concentration (Figure 3b). Further, both the span and the Hill slope of
the growth curve were also reduced at 163 μg/ml syncollin-Strep
(Figure 3c,d).
In contrast to the results for L. lactis, syncollin-Strep did not shift
the growth curve for E. coli, (Figure 4a), and the T50 value was unaf-
fected at all concentrations of the protein (Figure 4b). Syncollin-Strep
did, however, significantly reduce the span of the E. coli growth curves
at 81.5 and 163 μg/ml (Figure 4c). The Hill slope of the curve was
unaffected at all concentrations (Figure 4d). Hence, syncollin produces
different effects on the growth of Gram-positive and Gram-negative
bacteria.
As a control for the presence of protein in the growth medium,
the effects of soybean trypsin inhibitor and ribonuclease A on the
growth of L. lactis and E. coli were tested. As shown in Figure 5, nei-
ther protein shifted the growth curve for L. lactis (Figure 5a) or
reduced the span of the curve for E. coli (Figure 5b), under conditions
in which syncollin-Strep again caused clear effects, indicating that
syncollin specifically restricts the growth of both Gram-positive and
Gram-negative bacteria.
2.5 | Interactions between syncollin and
antibiotics
The effects of syncollin-Strep (110 μg/ml) on the growth of L. lactis in
combination with the antibiotics ampicillin (bactericidal) and tetracy-
cline (bacteriostatic) were assessed (Figure 6a,b). The concentrations
of the two antibiotics (0.05 and 2 μg/ml, respectively) were chosen so
as to produce a clear effect on bacterial growth but not to inhibit
growth completely. As shown in Figure 6c, syncollin-Strep, ampicillin
and tetracycline, when added alone, all failed to cause a significant
reduction in the span of the growth curve for L. lactis. However,
syncollin-Strep in combination with either ampicillin or tetracycline
did significantly reduce the span. None of the treatments used, either
alone or in combination, caused a significant effect on the T50 of the
F IGURE 2 Interaction of syncollin-Strep with peptidoglycan.
Syncollin-Strep and bovine serum albumin (BSA) (33 μg in both cases)
were incubated with insoluble peptidoglycan (PG; 320 μg). In a
control experiment, syncollin-Strep was also incubated without
PG. The PG was then pelleted by centrifugation, and the presence of
protein in the pellet and the supernatant was determined by either
immunoblotting (for syncollin-Strep) or Coomassie Blue staining (for
BSA). Molecular mass markers (in kDa) are indicated. The results are
representative of those from five experiments
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growth curve (Figure 6d). The additive effects of syncollin-Strep and
ampicillin are of particular interest because a bacteriostatic agent
would be expected to abrogate rather than enhance the effect of the
bactericidal ampicillin. This result suggests that syncollin-Strep might
be causing its own killing effect in addition to that brought about by
ampicillin.
F IGURE 3 Effect of syncollin-
Strep on the growth of Lactococcus
lactis. (a) Bacteria were incubated with
various concentrations of syncollin-
Strep and optical density (OD) at
600 nm was measured every 30 min
over a 20-hr time-course. Error bars
are SD (n = 3). (b–d) Effect of
syncollin-Strep, at various
concentrations, on (b) T50, the time
taken for the growth curve to reach
half of its maximal OD, (c) the increase
in OD over the course of the curve
(span), and (d) the Hill slope of the
curve. Data are from five experiments.
Error bars are SD. *p < .05; **p < .01,
compared with buffer control (one-
way Analysis of Variance [ANOVA]
with Dunnett's multiple comparisons)
F IGURE 4 Effect of syncollin-
Strep on the growth of Escherichia coli.
(a) Bacteria were incubated with
various concentrations of syncollin-
Strep and optical density (OD) at
660 nm was measured every 30 min
over a 20-hr time-course. Error bars
are SD (n = 3). (b–d) Effect of
syncollin-Strep, at various
concentrations, on (b) T50, the time
taken for the growth curve to reach
half of its maximal OD, (c) the increase
in OD over the course of the curve
(span), and (d) the Hill slope of the
curve. Data are from five experiments.
Error bars are SD. *p < .05; **p < .01,
compared with buffer control (one-
way Analysis of Variance [ANOVA]
with Dunnett's multiple comparisons)
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When added to E. coli, both ampicillin and tetracycline produced
a substantial flattening of the growth curve; in contrast, syncollin-
Strep was without obvious effect (Figure S1a,b). The reduction in the
span of the curve caused by both antibiotics was highly significant,
and the combination of syncollin-Strep with either antibiotic did not
cause a further reduction (Figure S1c,d).
2.6 | Syncollin reduces the viability of E. coli
Following our observations of effects on bacterial growth, we next
assessed bacterial viability after treatment with syncollin-Strep, ampi-
cillin and tetracycline through the uptake of propidium iodide, which
is taken up only by dead cells. Bacteria were sampled either in log
phase or plateau phase and incubated in a solution containing
propidium iodide (1 μg/ml). 40 ,60-Diamidino-2-phenylindole
dihydrochloride (DAPI) (1 μg/ml) was used to stain all of the bacterial
cells. As shown in Figure S2, in log phase, none of the three treat-
ments caused a significant increase in the numbers of propidium
iodide–positive (red) cells for either L. lactis or E. coli. In contrast, in
the plateau phase, ampicillin, but not tetracycline, caused significant
permeabilisation of both L. lactis and E. coli cells (Figure 7). Interest-
ingly, syncollin-Strep caused significant permeabilisation of E. coli but
not L. lactis. Further, both syncollin-Strep and ampicillin caused an
increase in the proportion of filamentous forms of E. coli (arrows,
Figure 7a), which are typically seen under conditions of cell stress
(Murashko & Lin-Chao, 2017). The permeabilising effect of syncollin-
Strep specifically on E. coli is consistent with the suggestion (above)
that the protein acts differentially on Gram-positive and Gram-
negative bacteria.
2.7 | Scanning electron microscopy shows
structural changes in response to syncollin treatment
To assess the effects of syncollin on the surfaces of L. lactis and E. coli
bacteria, we turned to scanning electron microscopy (SEM). Bacteria
were incubated in either buffer alone or in buffer containing
syncollin-Strep (0.3 mg/ml) before imaging. As shown in Figures 8, S3
and S4, control images reveal smooth-surfaced spherical (L. lactis) and
rod-shaped structures (E. coli). In contrast, bacteria treated with
syncollin-Strep were mis-shapen and rough-surfaced. These results
indicate profound structural changes to the bacteria brought about by
syncollin-Strep treatment, in parallel with the membrane per-
meabilisation described above. Incubation with trypsin inhibitor or
ribonuclease A caused only a modest increase in the surface rough-
ness of both types of bacteria, consistent with their lack of significant
effect on bacterial growth.
3 | DISCUSSION
We have shown here that syncollin hinders the growth of Gram-
positive (L. lactis) and Gram-negative (E. coli) bacteria, reducing the
viability of the latter in the plateau phase of growth. Syncollin also
causes obvious structural damage to the bacterial capsule in both
L. lactis and E. coli. Syncollin has two properties that are likely be
involved in its antibacterial activity – the ability to bind to peptidogly-
can, as demonstrated in this study, and the ability to permeabilise bio-
logical membranes (Wäsle et al., 2004) and lipid bilayers (Geisse
et al., 2002). We suggest that the slowing of the growth of L. lactis
(but not E. coli) in log phase might be caused primarily through binding
to the exposed peptidogycan-based cell wall in the former, whereas
the permeabilisation of the E. coli (but not L. lactis) in the plateau
phase might be caused by an action of syncollin on the membranes of
the Gram-negative bacterium. Further studies will be required to con-
firm this suggestion.
Syncollin-knockout mice are viable and fertile, although gut physi-
ology and sensitivity to bacterial challenge have not been addressed.
Given that a plethora of antibacterial polypeptides are known to be
secreted into the gut (see below), it is perhaps unlikely that the
absence of just one (syncollin) would cause an obvious gut phenotype.
Signs of abnormality in the pancreas of the knockout mice were
detected, including an increase in the numbers of ZGs within the aci-
nar cells and a reduction in the number of individual exocytotic events
(Wäsle et al., 2005). Could it be that a component of the exocytotic
machinery ‘moonlights’ as an antibacterial protein? At present, we
F IGURE 5 Control for the presence of protein in the incubation
medium. Bacterial growth curves for Lactococcus lactis (a) and
Escherichia coli (b) were generated in the presence of syncollin-Strep,
soybean trypsin inhibitor and RNase A (all at 300 μg/ml). Optical
density (OD) at 600 nm (L. lactis) or 660 nm (E. coli) was measured
every 30 min over a 20-hr time-course. Error bars are SD (n = 5).
The results are representative of those from three experiments
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F IGURE 6 Effect of syncollin-
Strep on the growth of Lactococcus
lactis in combination with antibiotics.
(a) Bacteria were incubated with
buffer alone, syncollin-Strep
(110 μg/ml), ampicillin (0.05 μg/ml) or
syncollin-Strep plus ampicillin, and
optical density (OD) at 600 nm was
measured every 30 min over a 20-hr
time-course. Error bars are SD (n = 4).
(b) Bacteria were incubated with
buffer alone, syncollin-Strep
(110 μg/ml), tetracycline (2 μg/ml) or
syncollin-Strep plus tetracycline, and
OD at 600 nm was measured every
30 min over a 20-hr time-course.
Error bars are SD (n = 4). (c,d) Effect
of syncollin and antibiotics, alone and
in combination, on (c) the span of the
curve and (d) the T50 of the curve.
Data are from five experiments. Error
bars are SD. *p < .05, compared with
buffer control (one-way Analysis of
Variance [ANOVA] with Tukey's
multiple comparisons)
F IGURE 7 Effect of syncollin-Strep
on bacterial viability in the plateau phase
of growth. Bacteria were incubated with
buffer alone, syncollin-Strep (300 μg/ml),
ampicillin (0.05 μg/ml) or tetracycline
(2 μg/ml). When bacteria reached the
early plateau phase of growth, they were
incubated in phosphate-buffered saline
(PBS) containing propidium iodide
(1 μg/ml; red) and 40,60-diamidino-
2-phenylindole dihydrochloride (DAPI)
(1 μg/ml; blue) before imaging by
confocal microscopy. (a) Representative
images for various conditions.
Filamentous forms of Escherichia coli are
indicated by arrows. Scale bar, 20 μm.
(b) Quantitation of results from three
experiments. *p < .05; **p < .01,
compared with buffer control (one-way
ANOVA with Dunnett's multiple
comparisons)
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cannot rule this out, although it is worth pointing out that compound
exocytosis continues at a reduced rate in the knockout mice, rather
than being completely abolished. Further, compound exocytosis
occurs in several other cell types (e.g., mast cells) that do not express
syncollin. It is clear that syncollin is a major component of the protein
matrix lining the luminal surface of the ZG membrane. It is therefore
possible that its absence in the knockout mouse causes structural
abnormalities that perturb the function of the membrane during
exocytosis.
Intriguingly, syncollin shares features with other small antimicro-
bial polypeptides that are known to play roles in host defence in the
gut, including ZG16p, RegIII and members of the defensin family.
These features include a predominantly beta-sheet structure, the
presence of intramolecular disulfide bonds, and in some cases, an abil-
ity to form homo-oligomers. ZG16p, like syncollin, is located on the
luminal surface of the pancreatic ZG membrane (Kalus et al., 2002). It
has a predominantly beta-sheet structure and contains a single intra-
molecular disulfide bond (Kanagawa et al., 2011). Members of the
regenerating islet-derived (Reg) protein family also adopt a predomi-
nantly beta-sheet structure. The family member RegIIIγ is secreted
into the intestinal lumen, where it has antibacterial actions (Shin &
Seeley, 2019). RegIIIα is capable of forming hexamers on bacterial
membranes, resulting in the formation of a transmembrane pore and
membrane leakiness (Mukherjee et al., 2014). Defensins are small pro-
teins (3–4 kDa), which have a predominantly beta-sheet structure
(Min et al., 2017), and six disulfide-bonded cysteines. Defensins, like
RegIIIα, are able to form pores and permeabilise bacterial membranes.
As mentioned above, syncollin is also expressed in (and secreted
from) neutrophils (Bach et al., 2006), again consistent with a role in
host defence. Indeed, the authors of this previous paper speculated
that syncollin might have an antibacterial effect but were unable to
demonstrate this property. We suggest that this failure might have
been a result of the elaborate method used to prepare native syncollin
(removal from the ZG membrane at high pH followed by selective pre-
cipitation in an aggregated state after dialysis to neutral pH; An
et al., 2000).
F IGURE 8 Scanning electron
microscopy (SEM) analysis of the
effects of syncollin-Strep and control
proteins on bacterial structure.
Bacteria were incubated in either
buffer alone or in buffer containing
protein (0.3 mg/ml) before SEM
imaging. Scale bar, 1 μm. The results
are representative of those from three
experiments
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In conclusion, given the structural similarities between the prop-
erties of syncollin and those of other known antimicrobial proteins,
together with the functional properties reported here, we propose
that syncollin is a previously unidentified member of the antimicrobial
protein superfamily. It is known that pancreatic juice has antibacterial
activity (Rubinstein et al., 1985), which is likely to be important not
only for the control of the bacterial flora of the upper intestine but
also for protection of the pancreas itself from infection. Structural
studies are currently underway to shed light on how syncollin folds,
oligomerises and interacts with its bacterial targets.
4 | EXPERIMENTAL PROCEDURES
4.1 | Syncollin construct
All enzymes, buffers and reagents were from NEB, unless otherwise
stated. A double-Strep-II tag was added to the syncollin sequence in
order to facilitate its isolation through binding to Strep-Tactin XT™
beads (IBA). A linker and a TEV-protease site were first added immedi-
ately downstream of the syncollin sequence. To achieve this, syncollin
DNA was amplified by polymerase chain reaction (PCR) to include
restriction enzyme sites for AgeI and NotI using the forward primer:
50-ATAACCGGTATGTCCCCGCTGTGCCTGCTGTTGC-30 and the
reverse primer: 50-ATAGCGGCCGCGCCCTGGAAGTACAGGTTCTCG
CCACCATAGCACTTGCAGTA-30. Two Strep-II tags were then
inserted downstream of the TEV site. These were amplified by PCR
from a vector kindly donated by Mekdes Debela (Department of Bio-
chemistry, University of Cambridge), using the forward primer:
50-ATAGCGGCCGTTGGAGTCATCCT-30 and the reverse primer:
50-ATACCTGCAGGTCATCACTTCTCAAACTG-30 to incorporate NotI
and SbfI restriction enzymes sites around the Strep-II tags for inser-
tion downstream of syncollin. The syncollin-Strep sequence was
cloned into a pcDNA3.1 backbone using the primers 50-AATAAG
CTTATGTCCCCGCTGTGCCTGCTGTTGCT-30 and 50-AATACCGG
TTCATCACTTCTCAAACTGTGGATGGG-30 to incorporate HindIII and
AgeI restriction sites. Syncollin-Strep was then ligated into the
HindIII- and AgeI-cleaved pcDNA3.1 backbone. The sequence of the
final construct was confirmed by Sanger sequencing.
4.2 | Syncollin purification
tsA-201 cells (a sub-clone of human embryonic kidney-293 cells sta-
bly expressing the SV40 large T-antigen) were grown in high-glucose
Dulbecco's modified Eagle's medium (DMEM; Sigma) containing 10%
(v/v) fetal bovine serum and 1% (w/v) penicillin/streptomycin
(Thermo) at 37C in an atmosphere of 5% (v/v) CO2/air. Cells were
transfected at 70–80% confluence using polyethyleneimine (Sigma)
and 19 μg DNA for each 175 cm2 flask. (A typical purification used
20 flasks.) Transfected cells were incubated for 96 hr to allow protein
expression. The cells were then centrifuged at 100g for 4 min, and the
supernatant was incubated with a 1:100 volume of Strep-Tactin XT™
beads for 3 hr at 4C. All subsequent steps were carried out at 4C.
Beads were pelleted by centrifugation for 5 min at 21,000g, and the
supernatant was discarded. The beads were resuspended in wash
buffer (10 mM sodium phosphate, pH 8.0) supplemented with cOm-
plete™ protease inhibitors (Sigma) and 0.1% (w/v) 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and
loaded into an Econo-Pac™ disposable chromatography column
(BioRad). The column was washed with 20 column volumes, and
bound protein was eluted using 7 x 2 column volumes of wash buffer
containing 50 mM biotin. All fractions were analysed using SDS-PAGE
followed by either Coomassie Blue staining or immunoblotting using a
rabbit polyclonal anti-syncollin antibody (Hodel & Edwardson, 2000).
Immunopositive bands were detected using a horseradish
peroxidase–conjugated goat anti-rabbit antibody (BioRad) and
enhanced chemiluminescence (Thermo). Syncollin-Strep was concen-
trated to 5 mg/ml (250 μM) using 10-kDa molecular mass cut-off con-
centrators (Amicon). After use, the Strep-Tactin XT™ beads were
regenerated for further use through addition of 40-
hydroxyazobenzene-2-carboxylic acid, which removes the bound
biotin.
4.3 | Syncollin quality control
To check for the presence of disulfide bonds, purified syncollin-Strep
was analysed by SDS-PAGE in the presence or absence of
β-mercaptoethanol, followed by assessment of band migration on an
immunoblot.
To check for syntaxin binding, GST-syntaxin 2 (C-terminal
domain, residues 181–264; Edwardson et al., 1997) was bound to
glutathione-Sepharose™ (Cytiva), and the beads were incubated with
purified syncollin-Strep for 3 hr at 4C. The supernatant was removed
for analysis, and the beads were washed with 10 bed volumes of
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid- (HEPES)-
buffered saline, pH 7.6 (HBS). A sample of the beads was then taken,
and the bound GST-syntaxin 2 was eluted with HBS containing
15 mM reduced glutathione. Syncollin in the bound, unbound and
eluted fractions was detected using SDS-PAGE followed by immuno-
blotting, using a polyclonal anti-syncollin antibody. As a negative con-
trol, GST was attached to the glutathione-Sepharose™ in place of
syntaxin 2.
4.4 | Circular dichroism spectroscopy
Syncollin-Strep was purified in 10 mM sodium phosphate, pH 8.0,
containing 0.1% (w/v) CHAPS, and diluted to 10 μM in the same
buffer, before 300 μl was added to a quartz cuvette for analysis using
a circular dichroism (CD) spectrophotometer (Applied Photophysics).
Far-UV CD data were collected between 200 and 280 nm using a
1-mm path length and a 2-nm bandwidth. A temperature ramp (25 to
95C) was applied, with 0.5 s per point. All readings were corrected
for the signal with buffer alone.
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4.5 | Peptidoglycan binding
Syncollin-Strep (100 μl of a 0.33 mg/ml solution in 10 mM sodium
phosphate, pH 8.0 containing 0.1% [w/v] CHAPS) was incubated
overnight at 4C, with agitation, with or without 320 μg insoluble pep-
tidoglycan (Sigma). Peptidoglycan was precipitated by centrifugation
at 21,000g for 3 min at 4C. The supernatants were retained, and the
peptidoglycan pellets were washed twice with ice-cold HBS. Superna-
tants and pellets were resuspended in equal volumes of sample buffer
and analysed by SDS-PAGE followed by immunoblotting, using a poly-
clonal anti-syncollin antibody. As a control, bovine serum albumin
(BSA) was used at the same concentration as syncollin in the binding
assay and visualised on gels by Coomassie Blue staining.
4.6 | Bacterial growth curves
Lactococcus lactis (Gram-positive) and Escherichia coli (Gram-negative)
were used to test for a potential antibacterial effect of syncollin.
L. lactis was grown in M17 media containing 0.5% (w/v) glucose under
anaerobic conditions at 30C. E. coli was grown in LB broth, at 37C,
with shaking at 220 rpm. Bacteria were inoculated from glycerol
stocks, and cultures were grown for 8 hr until an optical density
(OD) of 0.5 was reached. Bacterial growth curves were generated
by quantification of absorbance using a plate reader. A 96-well format
was used with a final volume of 100 μl per well. Syncollin-Strep
(or soybean trypsin inhibitor or ribonuclease A as control proteins), at
various concentrations, were added in a 50-μl volume to bacteria
diluted to OD 0.01 and 0.02 for E. coli and L. lactis, respectively.
Growth conditions were as described above. Negative controls
(syncollin elution buffer: 10 mM sodium phosphate, pH 8.0 containing
0.1% [w/v] CHAPS and 50 mM biotin) and positive controls
(40 mg/ml ampicillin) were included in all assays. OD was measured at
600 nm (for L. lactis) and at 660 nm (for E. coli). Plates were read every
30 min over a 20-hr period. Wells around the perimeter of the plates
were not used, and lids were left on the plates throughout to prevent
evaporation.
Ampicillin and tetracycline were used together with syncollin-
Strep to investigate the effects of combination treatment. Antibiotic
concentrations were selected such that bacterial growth occurred but
at a reduced rate compared with control; the ampicillin and tetracy-
cline concentrations chosen were 0.05 and 2 μg/ml, respectively. In
these experiments, syncollin was used at final concentration of
110 μg/ml.
Each condition was represented by multiple replicates in individ-
ual experiments, with independent repeats, and plate layouts were
changed in these repeats to rule out plate bias. Raw OD values
were corrected for the value at time zero, so that all growth curves
started at zero OD. The mean OD value in the plateau phase of
growth in the control (buffer-treated) curve was taken as 100%
growth, and all other data were expressed as a percentage of this
value. Nonlinear regression (four parameters) was applied to generate
growth curves using GraphPad Prism™. The bottom of the curve was
set to zero, and Hill slopes were constrained to <0.1 in order to
eliminate ambiguous fits. Three growth parameters were derived from
each curve: T50, the time taken for the curve to reach half of its maxi-
mal OD; span, a measure of the increase in OD over the course of the
curve, and Hill slope, a measure of the slope of the log phase of the
curve. Data from independent experiments were combined. Statistical
analysis used one-way ANOVA with Dunnett's or Tukey's multiple
comparisons, as appropriate.
4.7 | Bacterial viability assay
Bacteria were inoculated from glycerol stocks into 5 ml of appropriate
media (see above) for overnight culture. Bacteria were then diluted to
OD 0.01 and incubated under various conditions: buffer alone [con-
trol] (5 mM sodium phosphate, pH 8.0 containing 0.05% [w/v]
CHAPS, 25 mM biotin and complete protease inhibitors), or
300 μg/ml syncollin, 0.05 μg/ml ampicillin and 2 μg/ml tetracycline in
the same buffer. OD was monitored at either 600 nm (L. lactis) or
660 nm (E. coli) until bacteria reached the early plateau phase of
growth (OD 0.35 for L. lactis and 2.2 for E. coli). Bacteria were col-
lected by centrifugation at 1,000g for 2 min. Bacterial pellets were
washed once with phosphate-buffered saline, pH 7.4 (PBS) before
resuspension in PBS containing 1 μg/ml propidium iodide and 1 μg/ml
DAPI. Resuspended bacteria were incubated in the dark for 20 min at
room temperature and then added to poly-L-lysine coated 18-well flat
imaging plates (Ibidi) before confocal imaging.
Confocal imaging settings were identical for all conditions for
each bacterial strain. Raw images were incorporated into image com-
posites using ImageJ™. Brightness was adjusted identically for all
images within an experiment so that red and blue staining could be
clearly identified. Red staining and red plus blue staining was quanti-
fied using set colour thresholding and area measurement using
ImageJ. The percentage of red (dead) cells relative to red plus blue
(total) cells were then calculated. For each experiment, at least three
images were analysed, and a mean percentage dead cells was deter-
mined. Data from independent experiments were then combined. Sta-
tistical analysis used one-way ANOVA with Dunnett's multiple
comparisons with buffer control.
4.8 | Scanning electron microscopy imaging of
syncollin-treated bacteria
Lactococcus lactis and Escherichia coli were incubated with syncollin-
Strep, or either soybean trypsin inhibitor or ribonuclease A as control
proteins, as described above. For L. lactis, 13-mm coverslips were
washed with acetone for 5 min before coating with a 50:1 (v/w) ace-
tone:Vectabond™ solution for 5 min. For E. coli, coverslips were
washed with water before coating with 0.1% (w/v) poly-L-lysine
(Sigma) for 30 min at room temperature. Once coated, coverslips were
washed three times with water and dried in a stream of nitrogen. Bac-
teria in the plateau phase of their growth curves were allowed to
adhere to coated coverslips for 30 min at room temperature. Cover-
slips were very briefly dipped twice in cold, de-ionised water to
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remove any buffer salts and then quickly plunge-frozen by dipping
into liquid nitrogen-cooled ethane. Samples were transferred to liquid
nitrogen–cooled brass inserts and freeze-dried overnight in a
liquid nitrogen–cooled turbo freeze-drier (Quorum K775X). Samples
were mounted on aluminium SEM stubs using conductive silver paint
(TAAB) and sputter-coated with 20-nm gold using a Quorum K575X
sputter coater. Samples were viewed using an FEI Verios 460 scanning
electron microscope run at 1 keV and 25 pA probe current. Images
were acquired in SE-mode using an Everhard-Thornley detector.
ACKNOWLEDGEMENTS
We are grateful to Karin Muller of the Cambridge Advanced Imaging
centre for her help with the SEM imaging, to Mekdes Debela of the
Department of Biochemistry, University of Cambridge for the Strep
tagging vector, and to the following members of the Department of
Pharmacology, University of Cambridge: Marie Synakewicz, Rohan
Eapen, Pam Rowling and other members of the Laura Itzhaki labora-
tory for help with the purification of syncollin, Sagar Raturi and Rik
van Veen for help with the bacterial growth assays and Rachel Lee
and Sophie Wainwright of the Edwardson laboratory for technical
assistance. R.A.W. is supported by an AstraZeneca Graduate Student-
ship and a David James Studentship from the Department of
Pharmacology.
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest regarding
the contents of this article.
AUTHOR CONTRIBUTIONS
James Robinson and J. Michael Edwardson: Designed the study.
Rosie A. Waters: Conducted the experiments and analysed the data.
All three authors wrote the manuscript.
DATA AVAILABILITY STATEMENT
Data supporting the findings of this study are available from the
corresponding author upon reasonable request.
ORCID
J. Michael Edwardson https://orcid.org/0000-0003-0499-7795
REFERENCES
An, S. J., Hansen, N. J., Hodel, A., Jahn, R., & Edwardson, J. M. (2000).
Analysis of the association of syncollin with the membrane of the pan-
creatic zymogen granule. Journal of Biological Chemistry, 275, 11306–
11311.
Bach, J. -P., Borta, H., Ackermann, W., Faust, F., Borchers, O., &
Schrader, M. (2006). The secretory granule protein syncollin localizes
to HL-60 cells and neutrophils. Journal of Histochemistry and Cyto-
chemistry, 54, 877–888.
Edwardson, J. M., An, S., & Jahn, R. (1997). The secretory granule protein
syncollin binds to syntaxin in a Ca2+-sensitive manner. Cell, 90,
325–333.
Fukushima, K., Funayama, Y., Ogawa, H., Takahashi, K. I., & Sasaki, I.
(2003). Decreased expression of syncollin mRNA in colonic epithelial
cells of bacteria-challenged germ-free mice and ulcerative colitis. Gas-
troenterology, 124, A329.
Geisse, N. A., Wäsle, B., Saslowsky, D. E., Henderson, R. M., &
Edwardson, J. M. (2002). Syncollin homo-oligomers associate with lipid
bilayers in the form of doughnut-shaped structures. Journal of Mem-
brane Biology, 189, 83–92.
Hodel, A., & Edwardson, J. M. (2000). Targeting of the zymogen-granule
protein syncollin in AR42J and AtT-20 cells. Biochemical Journal, 350,
637–643.
Kalus, I., Hodel, A., Koch, A., Kleene, R., Edwardson, J. M., & Schrader, M.
(2002). Interaction of syncollin with GP-2, the major membrane pro-
tein of pancreatic zymogen granules, and association with lipid micro-
domains. Biochemical Journal, 362, 433–442.
Kanagawa, M., Satoh, T., Ikeda, A., Nakano, Y., Yagi, H., Kato, K., …
Yamaguchi, Y. (2011). Crystal structures of human secretory proteins
ZG16p and ZG16b reveal a Jacalin-related β-prism fold. Biochemical
and Biophysical Research Coomunications, 404, 201–205.
Li, X., Gao, Y., Yang, M., Zhao, Q., Wang, G., Yang, Y. M., … Zhang, Y.
(2014). Identification of gene expression changes from colitis to CRC
in the mouse CAC model. PLoS One, 9, e95347.
Makawita, S., Dimitromanolakis, A., Soosaipillai, A., Soleas, I., Chan, A.,
Gallinger, S., … Diamandis, E. P. (2013). Validation of four candidate
pancreatic cancer serological biomarkers that improve the perfor-
mance of CA19.9. BMC Cancer, 13, 404. https://doi.org/10.1186/
1471-2407-13-404
Makawita, S., Smith, C., Batruch, I., Zheng, Y., Rückert, F., Grützmann, R., …
Diamandis, E. P. (2011). Integrated proteomic profiling of cell line con-
ditioned media and pancreatic juice for the identification of pancreatic
cancer biomarkers. Molecular and Cellular Proteomics, 10,
M111.008599. https://doi.org/10.1074/mcp.M111.008599
Min, H. J., Yun, H., Ji, S., Rajasekaran, G., Kim, J. I., Kim, J. S., … Lee, C. W.
(2017). Rattusin structure reveals a novel defensin scaffold formed by
intermolecular disulfide exchanges. Scientific Reports, 7, 45282.
Mukherjee, S., Zheng, H., Derebe, M. G., Callenberg, K. M., Partch, C. L.,
Rollins, D., … Hooper, L. V. (2014). Antibacterial membrane attack by a
pore-forming intestinal C-type lectin. Nature, 505, 103–107.
Murashko, O. N., & Lin-Chao, S. (2017). Escherichia coli responds to envi-
ronmental changes using enolasic degradosomes and stabilized DicF
sRNA to alter cellular morphology. Proceedings of the National Academy
of Sciences of the United States of America, 114, E8025–E8034.
Rubinstein, E., Mark, Z., Haspel, J., Ben-Ari, G., Dreznik, Z., Mirelman, D., &
Tadmor, A. (1985). Antibacterial activity of the pancreatic fluid. Gastro-
enterology, 88, 927–932.
Shin, J. H., & Seeley, R. J. (2019). Reg3 proteins as gut hormones? Endocri-
nology, 160, 1506–1514.
Tan, S., & Hooi, S. C. (2000). Syncollin is differentially expressed in rat
proximal small intestine and regulated by feeding behavior. The Ameri-
can Journal of Physiology, 278, G308–G320.
Wäsle, B., Hays, L. B., Rhodes, C. J., & Edwardson, J. M. (2004). Syncollin inhibits
regulated corticotropin secretion from AtT-20 cells through a reduction in
the secretory vesicle population. Biochemical Journal, 380, 897–905.
Wäsle, B., Turvey, M., Larina, O., Thorn, P., Skepper, J., Morton, A. J., &
Edwardson, J. M. (2005). Syncollin is required for efficient zymogen
granule exocytosis. Biochemical Journal, 385, 721–727.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Waters, R. A., Robinson, J., &
Edwardson, J. M. (2021). Syncollin is an antibacterial
polypeptide. Cellular Microbiology, e13372. https://doi.org/10.
1111/cmi.13372
10 of 10 WATERS ET AL.
